Identification and quantitation of blasts in myeloid malignancies with marrow fibrosis or marrow hypoplasia and CD34 negativity
Open Access
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AMLClinical Lymphoma Myeloma and Leukemia, 2020
- Prognostic relevance of CD123 expression in adult AML with normal karyotypeBritish Journal of Haematology, 2020
- CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotypingCytometry Part B: Clinical Cytometry, 2018
- Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission?Journal of Clinical Oncology, 2016
- Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact on Outcome in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2015
- The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemiaAmerican Journal of Hematology, 2015
- Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemiaLeukemia, 2013
- Involvement of E-cadherin in the Development of Erythroid CellsHematology, 2000
- Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: Analysis of 141 casesLeukemia Research, 1997